吉非替尼 (ZD1839)

Gefitinib (ZD1839) (订货以英文为准)

编号:G125799
CAS号:184475-35-2
分子式:C22H24CLFN4O3
分子量:446.90
货号 品牌 包装 目录价 您的价格 库存 数量 购买
G125799-1g 阿拉丁 1g ¥63.90
G125799-50mg 阿拉丁 50mg ¥30.90
G125799-5g 阿拉丁 5g ¥185.90
G125799-100g 阿拉丁 100g ¥2473.90
G125799-250mg 阿拉丁 250mg ¥41.90
G125799-25g 阿拉丁 25g ¥673.90
G125799-10g 阿拉丁 10g ¥342.90
产品名称 Gefitinib (ZD1839)
中文名称 吉非替尼 (ZD1839)
CAS号 184475-35-2
分子式(M.F.) C22H24CLFN4O3
分子量(M.W.) 446.90
储存条件 2-8°C储存
沸点586.8 °C
旋光率1.62
溶解性Soluble in DMSO (89 mg/ml at 25 °C), methanol (20 mg/ml), ethanol (4 mg/ml at 25 °C), DMF (20 mg/ml), and water (<1 mg/ml at 25 °C).
应用An EGFR-tyrosine kinase inhibitor
产品介绍Gefitinib (ZD1839)是一种EGFR抑制剂,作用于NR6wtEGFR和NR6W细胞中的Tyr1173,Tyr992,Tyr1173和Tyr992,IC50 分别为37 nM,37nM,26 nM和57 nM。
备注Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
生化机理Gefitinib is an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and has been shown to increase phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in HaCaT cells. Studies suggest that gefitinib can enhance keratinocyte apoptosis via an EGFR-independent JNK-activation pathway. Research indicates that gefitinib can induce apoptosis in several cell lines including, HaCaT cells, KG-1, P39, and primary CD34+ myeloblasts.
别名ZD 1839;吉非替尼; N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺;ZD 1839;Iressa;ZD-1839; ZD1839;N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:23420-88-4
¥ 325.00 C834309-100mg
CAS号:7646-85-7
¥ 451.90 Z112526-500g-50g
¥ 1890.00 CR-070S-1台
CAS号:110-54-3
¥ 156.90 H109656-500ml
¥ 98.00 sh5670-1片
¥ 98.00 sh024578-1片
¥ 120.00 sh02432-250mL
¥ 120.00 sh024431-250mL
¥ 120.00 sh024430-250mL
CAS号:1923-70-2
¥ 471.00 01038706-100g